The ad is slated to air during the Super Bowl on Sunday to more than 120 million Americans, wrote the lawmakers, yet runs the risk of misleading patients by omitting safety or side effect information. Under section 502 of the federal Food, Drug and Cosmetic Act (FDCA), they pointed out, FDA is required to ensure that prescription drug ads be truthful, not misleading, and balanced
Put the Moose on the Table: Lessons in Leadership from a CEO's Journey through Business and Life
No matter what your weight loss goals are, semaglutide may be a viable solution to assist you in achieving them
For some people, it doesnt necessarily correlate with their medical conditions. Ali added that, regardless of the drug or the persons medical conditions, weight loss in obesity is a difficult, multifactorial problem that requires careful tailoring and commitment
World Anti-Doping Agency Prohibited List, Section S2: Peptide Hormones, Growth Factors, Related Substances (growth hormone secretagogues)
Is the cost we pay for something worth the benefit we derive from it